Stock Forecast

  IntriCon Corporation ( IIN) Stock. Should you Buy or Sell?    $ 24.23

0.03 (0.12 %)

IntriCon Corporation Analysis

Updated on 10-09-2022
Symbol IIN
Price $24.23
Beta 1.005
Volume Avg. $108 thousand
Market Cap $221.54 M
52 Week Range $12.47 - $24.93

IntriCon Corporation opened the day at $24.23 which is +'0.12 % on yesterday's close. IntriCon Corporation has a 52 week high of $24.93 and 52 week low of $12.47, which is a difference of $12.46. We like to see positive, upward trending shares, preferably with momentum. Market capitalization is $221.54 M and total net profit is $125206000 which means the company is trading at 1.77 times profit to market capitalization. Theoretically, if you were to buy IntriCon Corporation for $221.54 M, it would take 15 years to get your money back. IntriCon Corporation are in the Medical Instruments & Supplies space which will have a sweet spot and industry standard for net profit multiples.

Price Chart

1 D | All


IntriCon Corporation Stock Forecast - Is IntriCon Corporation a Buy or Sell?

DCF ScoreStrong Buy
ROE ScoreNeutral
ROA ScoreNeutral
DE ScoreNeutral
PE ScoreStrong Sell
PB ScoreStrong Buy
Overall RecommendationBuy

Growth and Value

PE Ratio 226.449
Dividend Yiel 0.000
Net Profit Margin -0.012

Valuing IntriCon Corporation

Price Book Value Ratio 2.396 Price To Book Ratio 2.396
Price To Sales Ratio 1.773 Price Earnings Ratio -151.844

How liquid is IntriCon Corporation

Current Ratio 3.199
Quick Ratio 1.856


Debt Ratio 0.259 Debt Equity Ratio 0.350
Long Term Debt To Capitalization 0.045 Total Debt To Capitalization 0.064

Latest news about IntriCon Corporation

TTDKY vs. IIN: Which Stock Should Value Investors Buy Now?

TTDKY vs. IIN: Which Stock Is the Better Value Option?

Date : 28/03/2022

Date : 01/03/2022

IntriCon Corporation (IIN) Stock: Why It Surged Today

The IntriCon Corporation (NASDAQ: IIN) stock increased by 37.37% today. This is why.

Date : 28/02/2022

Why Are Intricon Shares Surging Monday

Altaris Capital Partners LLC will acquire Implantable device maker Intricon Corporation (NASDAQ: IIN) for $24.25 per share in a transaction that values Intricon at an equity value of approximately $241 million.  The purchase price represents a premium of approximately 39%.

Date : 28/02/2022

TTDKY vs. IIN: Which Stock Is the Better Value Option?

TTDKY vs. IIN: Which Stock Is the Better Value Option?

Date : 23/02/2022

About IntriCon Corporation

CEO : Mr. Mark Gorder
Sector : Healthcare
Industry : Medical Instruments & Supplies

Website :

Exchange : NASDAQ Global Market

Description :

IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. It offers micro-miniature products, microelectronics, micro-mechanical assemblies, high-precision injection-molded plastic components, and assemblies and software solutions for medical devices, hearing healthcare, and professional audio communication devices markets. The company also provides micro coils for surgical navigation clinical applications, such as interventional pulmonology and electrophysiology; joint engineering and manufacturing services for complex medical devices, including catheters covering a range of applications for cardiology, peripheral vascular, neurology, radiology, and pulmonology; bubble sensors and flow restrictors that monitor and control the flow of fluid in an intravenous infusion system; and safety needle products for original equipment manufacturing customers. In addition, it offers professional audio headset products used for emergency response needs in the fire, law enforcement, safety, aviation, and military markets; and a line of miniature ear- and head-worn devices used by performers and support staff in the music and stage performance markets. The company sells its hearing device products, and medical and professional audio communications products directly to hearing instrument manufacturers, distributors, and partnerships; and microphone products to the radio communication and professional audio industries, as well as markets and sells hearing aid devices directly to consumers through direct mail advertising, Internet, and call center. The company was formerly known as Selas Corporation of America and changed its name to IntriCon Corporation. The company was incorporated in 1930 and is headquartered in Arden Hills, Minnesota.

My Newsletter

Sign Up For Updates & Newsletters